Cargando…
Side effects of drugs annual. a worldwide yearly survey of new data in adverse drug reactions / Volume 40 :
Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 40, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a rel...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam, Netherlands :
Elsevier,
[2�018]
|
| Edición: | First edition. |
| Colección: | Side Effects of Drugs Annual ;
Volume 40 |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover
- Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
- Copyright
- Contributors
- Contents
- Preface
- Special Reviews in SEDA 40
- Table of Essays, Annuals 1-39
- Abbreviations
- ADRs, ADEs and SEDs: A Bird's Eye View
- Introduction
- Analysis of ADEs, ADRs, Side Effects and Toxicity
- Terminology
- EIDOS
- DoTS
- WHO Classification
- References on Adverse Drug Reactions
- Further Reading
- Pharmacogenomics Considerations
- Enzymes and Transporters
- Human Leukocyte Antigens (HLA)
- Genetic Testing Technology
- Conclusion
- References
- Further Reading
- Immunological Reactions
- Type I Reactions (IgE-Mediated Anaphylaxis
- Immediate Hypersensitivity)
- Type II Reactions (Cytotoxic Reactions)
- Type III Reactions (Immune Complex Reactions)
- Type IV Reactions (Cell-Mediated or Delayed Hypersensitivity Reactions)
- Other Types of Reactions
- References
- Further Reading
- Analysis of Toxicological Reactions
- Potentiation Reactions
- Examples
- Synergistic Effect
- Additive Effect
- Examples
- Antagonistic Effects
- Examples
- Cross References
- Grades of Adverse Drug Reactions
- References
- FDA Pregnancy Categories/Classification of Teratogenicity
- Category A
- Category B
- Category C
- Category D
- Category X
- Category N
- References
- Clinicians are suggested to be aware of the information contained in the following literature originating from regulatory agen
- Conclusion
- Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite
- Amphetamine and Amphetamine Derivates [SEDA-35, 1
- SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Organs and Systems
- Cardiovascular
- Nervous System
- Gastrointestinal
- Death
- Ecstasy (3,4-Methylenedioxy-N-Methylamphetamine, MDMA)
- Organs and Systems.
- Pulmonary
- Liver
- Nervous System
- Death
- Methylphenidate [SEDA-35, 1
- SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Organs and Systems
- Nervous System
- Hair
- Skin
- Drug-Drug Interaction
- Methylxanthines
- Caffeine [SEDA-33, 11
- SEDA-34, 6
- SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Organs and Systems
- Nervous System
- Drug-Drug Interaction
- Selective Norepinephrine Reuptake Inhibitors Atomoxetine [SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Organ and Systems
- Nervous System
- Drug-Drug Interactions
- Vigilance Promoting Drugs
- Modafinil and Armodafinil [SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Organs and Systems
- Drug-Drug Interactions
- Pitolisant
- Drugs That Suppress Appetite [SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Phentermine [SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Organs and Systems
- Renal
- Naltrexone Sustained-Release/Bupropion Sustained-Release [SEDA-37, 1]
- Organs and Systems
- Skin
- Drug-Drug Interactions
- Parasympathomimetics [SEDA-34, 9
- SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1]
- Donepezil [SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Organ and Systems
- Cardiovascular
- Musculoskeletal
- Memantine [SEDA-34, 1
- SEDA-39, 1]
- Organ and Systems
- Skin
- Musculoskeletal
- Rivastigmine [SEDA-36, 1
- SEDA-37, 1
- SEDA-38, 1
- SEDA-39, 1]
- Organ and Systems
- Cardiovascular
- Musculoskeletal
- References
- Chapter 2: Antidepressants
- General
- Hematological
- Upper Gastrointestinal Bleeding
- Postpartum Hemorrhage
- Venous Thromboembolism
- Nervous System
- Stroke
- Seizures
- Jitteriness
- Emotional Blunting
- Cardiovascular
- Vascular Outcomes
- Acute Myocardial Infarction
- Endocrine
- Type 2 Diabetes
- Pancreatitis.
- Reproductive System (Pregnancy, Development and Infancy)
- Pregnancy
- Fetal Malformations
- Preeclampsia
- Persistent Pulmonary Hypertension of the Newborn
- Childhood Psychiatric Disorders
- Autism
- ADHD
- Falls and Fractures
- Sensory Systems
- Glaucoma
- Cataracts
- Selective Serotonin Reuptake Inhibitors
- Fluoxetine
- Interstitial Lung Disease
- References
- Chapter 3: Lithium
- Introduction
- Organs and Systems
- Nervous System
- Cardiovascular
- Renal
- Endocrine
- Dermatologic
- Pregnancy
- Drug-Drug Interactions
- References
- Chapter 4: Drugs of Abuse
- Introduction
- Cannabinoids: Synthetic (Hong)
- Cardiovascular
- Respiratory
- Nervous System
- Urinary Tract
- Hepatic
- Drug-Drug Interactions
- Cannabinoids: Non-Synthetic (Hong)
- Cardiovascular
- Gastrointestinal Tract
- Mineral Balance
- Nervous System
- Drug-Drug Interactions
- Pregnancy
- Age
- Cannabinoids (Ku)
- Pharmacogenetics
- Alcohol (BABIN)
- Cardiovascular
- HEENT
- Nervous System
- Sensory Systems
- Endocrine
- Gastrointestinal
- Skin
- Musculoskeletal
- Immunologic
- Tumorigenicity
- Age
- Alcohol (Ku)
- Pharmacogenetics
- Benzodiazepines (May)
- Cardiovascular
- Oncology
- CNS
- Migraine
- Cognitive Decline
- Orthopedic
- Hepatic
- HEENT
- Sympathomimetics: Cocaine (May)
- HEENT
- Splenic
- CNS
- Thrombosis
- Sympathomimetics: Methamphetamine
- Pulmonary
- Endocrine
- Gastrointestinal
- Cathinones: Non-Synthetic
- General Information
- Khat Overdose
- Cathinones: Synthetic (Wisner, Hall)
- General Information
- Cardiovascular
- Nervous System/Psychological
- Death
- Pharmacogenetics
- Heroin (Babin)
- Cardiovascular
- Respiratory
- CNS
- Hematologic
- Musculoskeletal
- Heroin (Ku)
- Pharmacogenetics
- Prescription/Over-the-Counter Opioids and NPS (FUDIN)
- Population.
- Law (Regulations)
- Cardiovascular
- Endocrine
- Glucose Metabolism (Methadone)
- Glucose Metabolism (Buprenorphine)
- Testosterone
- Gastrointestinal
- HEENT
- Dental
- Eye
- Nasal
- Immunologic
- Hematologic
- Nervous System
- Serotonin Syndrome
- CNS
- Cognition
- Behavioral
- Mental Illness Associated Overdose
- Respiratory
- Renal
- NPS
- Fentanyl Analogs
- MT-45
- U-47700
- Opioid Withdrawal
- Symptoms and AE
- OUD Withdrawal treatment
- Abuse-Deterrent
- Tapentadol
- Buprenorphine
- NAS
- Death
- Prescription/Over-the-Counter Opioids and Fentanyl Analogs (Ku)
- Pharmacogenetics
- Conclusion (Precautionary Note to Clinicians)
- References
- Chapter 5: Hypnotics and Sedatives
- Benzodiazepines and Non-Benzodiazepine Gamma-Aminobutyric Acid (GABA) Agonists [SEDA-37, 5
- SEDA-38, 4
- SEDA-39, 5]
- Review
- Musculoskeletal System
- Infection Risk
- Benzodiazepines [SEDA-37, 5
- SEDA-38, 4
- SEDA-39, 5]
- Special Review
- Central Nervous System
- Cardiovascular System
- Respiratory System
- Immunologic System
- Prenatal Exposure
- Non-Benzodiazepine GABA Agonists [SEDA-37, 5
- SEDA-38, 4
- SEDA-39, 5]
- Central Nervous System
- Infection Risk
- Ketamine [SEDA-39, 5]
- Review
- Cardiovascular System
- Endocrine System
- Infant Exposure
- Drug-Drug Interaction
- Melatonin Receptor Agonists
- l-Tryptophan
- Melatonin [SEDA-37, 5]
- Orexin Receptor Antagonists
- Almorexant
- Elderly
- Filorexant
- Suvorexant
- Elderly
- Adolescents
- Propofol [SEDA-38, 4
- SEDA-39, 5]
- Cardiovascular System
- Infection Risk
- References
- Chapter 6: Antipsychotic Drugs
- General [SEDA-35, 85
- SEDA-36, 59
- SEDA-37, 63
- SEDA-38, 35
- SEDA-39, 65]
- Comparative Studies
- Observational Studies
- Systematic Reviews
- Cardiovascular
- Ear, Nose, Throat
- Nervous System.
- Sensory Systems
- Endocrine
- Metabolism
- Hematologic
- Skin
- Musculoskeletal
- Urinary Tract
- Sexual Function
- Reproductive Function
- Breasts
- Immunologic
- Death
- Drug-Drug Interactions
- Diagnosis of Adverse Drug Reactions
- Individual Drugs
- Amisulpride [SEDA-36, 59
- SEDA-37, 67
- SEDA-38, 38
- SEDA-39, 69]
- Controlled Studies
- Observational Studies
- Nervous System
- Psychiatric
- Urinary Tract
- Aripiprazole [SEDA-35, 96
- SEDA-36, 59
- SEDA-37, 68
- SEDA-38, 38
- SEDA-39, 69]
- Controlled Studies
- Observational Studies
- Systematic Reviews
- Cardiovascular
- Respiratory
- Nervous System
- Psychiatric
- Electrolyte Balance
- Hematologic
- Urinary Tract
- Skin
- Sweat Glands
- Musculoskeletal
- Susceptibility Factors
- Drug-Drug Interactions
- Asenapine [SEDA-37, 69
- SEDA-38, 39
- SEDA-39, 70]
- Controlled Studies
- Observational Studies
- Systematic Reviews
- Nervous System
- Brexpiprazole [SEDA-38, 40
- SEDA-39, 71]
- Observational Studies
- Systematic Reviews
- Cariprazine (SEDA-38, 40
- SEDA-39, 40)
- Observational Studies
- Chlorpromazine [SEDA-35, 85
- SEDA-36, 59
- SEDA-37, 69
- SEDA-38, 40
- SEDA-39, 71]
- Sensory Systems
- Clozapine [SEDA-35, 99
- SEDA-36, 59
- SEDA-37, 69
- SEDA-38, 40
- SEDA-39, 72]
- Observational Studies
- Systematic Reviews
- Cardiovascular
- Respiratory
- Nervous System
- Neuromuscular Function
- Eyes
- Endocrine
- Metabolic
- Hematologic
- Gastrointestinal
- Sexual Function
- Immunologic
- Body Temperature
- Second-Generation Effects
- Susceptibility Factors
- Drug-Drug Interactions
- Fluphenazine [SEDA-37, 71
- SEDA-39, 74]
- Musculoskeletal
- Haloperidol [SEDA-35, 107
- SEDA-36, 59
- SEDA-37, 72
- SEDA-38, 42
- SEDA-39, 74]
- Systematic Reviews
- Cardiovascular System
- Nervous System
- Overdose.